PPARGC1A and diabetes mellitus: These results suggest that SR promoted DM-induced cardiac dysfunction and hypertrophy; exacerbated mitochondrial damage through inhibition of the PRDM16/PGC-1α pathway; and exacerbated cardiac fibrotic remodeling and cardiac dysfunction through promotion of oxidative stress and inflammatory responses, which ultimately induced increased mortality.